Literature DB >> 8354326

Hepatorenal failure after carbamazepine therapy.

N Hadzić.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8354326     DOI： 10.1007/bf01954096

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  8 in total

1.  Severe hepatorenal failure in a child receiving carbamazepine and erythromycin.

Authors:  F Viani; A Claris-Appiani; L N Rossi; M Giani; A Romeo
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

2.  Fatal carbamazepine hepatitis.

Authors:  P Zucker; F Daum; M I Cohen
Journal:  J Pediatr       Date:  1977-10       Impact factor: 4.406

3.  Epidemiology of adverse reactions to carbamazepine as seen in a spontaneous reporting system.

Authors:  H Askmark; B E Wiholm
Journal:  Acta Neurol Scand       Date:  1990-02       Impact factor: 3.209

4.  Fatal hepatic necrosis associated with multiple anticonvulsant therapy.

Authors:  D W Smith; G J Cullity; E P Silberstein
Journal:  Aust N Z J Med       Date:  1988-06

5.  Carbamazepine-induced acute tubulointerstitial nephritis.

Authors:  R J Hogg; M Sawyer; K Hecox; E Eigenbrodt
Journal:  J Pediatr       Date:  1981-05       Impact factor: 4.406

6.  Acute liver failure induced by carbamazepine.

Authors:  N Hadzić; B Portmann; E T Davies; A P Mowat; G Mieli-Vergani
Journal:  Arch Dis Child       Date:  1990-03       Impact factor: 3.791

Review 7.  Hepatotoxic reactions associated with carbamazepine therapy.

Authors:  S Horowitz; R Patwardhan; E Marcus
Journal:  Epilepsia       Date:  1988 Mar-Apr       Impact factor: 5.864

Review 8.  Hepatic considerations in the use of antiepileptic drugs.

Authors:  F E Dreifuss; D H Langer
Journal:  Epilepsia       Date:  1987       Impact factor: 5.864
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.